Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies? (Q56940101)

From Wikidata

Jump to navigation Jump to search

article by László Maródi & Jean-Laurent Casanova published May 2010 in Nature Reviews Immunology

Language	Label	Description	Also known as
English	Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?	article by László Maródi & Jean-Laurent Casanova published May 2010 in Nature Reviews Immunology

Statements

scholarly article

0 references

Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies? (English)

0 references

1 reference

based on heuristic

inferred from title

Jean-Laurent Casanova

object named as

Jean-Laurent Casanova

2

0 references

László Maródi

1

object named as

László Maródi

0 references

publication date

May 2010

0 references

Nature Reviews Immunology

0 references

10

0 references

5

0 references

299-300

0 references

Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

21 January 2018

Infectious complications of tumor necrosis factor blockade

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Infectious complications of biologic agents

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Problems encountered during anti-tumour necrosis factor therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Primary immunodeficiencies: a field in its infancy

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Immunological and genetic bases of new primary immunodeficiencies

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1.

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

The late adverse events of rituximab therapy--rare but there!

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Tolerability and safety of rituximab (MabThera).

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Risk factors for infection in haematology patients treated with rituximab.

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Enterovirus infection of neuronal cells post-Rituximab

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Biologic agents for the treatment of juvenile rheumatoid arthritis: current status

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Reemergence of PML in natalizumab-treated patients--new cases, same concerns

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Primary immunodeficiency diseases: the J Project

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FNRI2764

31 March 2020

Identifiers

10.1038/NRI2764

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56940101&oldid=2119179291"